A Randomized controlled clinical trial to evaluate the efficacy between Aatarushadi Kwath Ghana Vati and Kaishore Guggul in the management of Vatarakta.

PDEAS College of Ayurved and Research Center Pradhikaran Nigdi Pune0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients having clinical signs and symptoms of Vatrakta such as Sandhi shula/Toda (Pain), Sandhi Shotha (swelling), Sparshaashatva (Tenderness), Chimichimayan (tingling sensation),team vaivarnya (Discoloration Of skin).
•Age group having 20 to 65 years irrespective of religion, gender, socioeconomic status.
•Patient having serum uric acid more than 7 mg/dl in male and more than 6mg/dl in female.

•Known case of Amavata, Sandhigata vata, SLE, Renal Disease
•Known case of tuberculosis of any system
•Chronic joint deformity
•Hypersensitive reaction to any drug
•Patients with chronic major illness
•High risk (above 65 yrs age,known cases of HTN,DM,COPD),Comorbid patients Suspected for Covid-19. Suspected Covid-19
•patients having symptoms as per ICMR guidelines.

发起方

PDEAS College of Ayurved and Research Center Pradhikaran Nigdi Pune